secwatch.observer — SEC 8-K summary
======================================

Issuer:     Protagenic Therapeutics, Inc.new (PTIX)
CIK:        0001022899
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001641172-25-016979
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Protagenic Therapeutics declares rights offering at $0.01 per share to preserve ownership after Phytanix acquisition
--------------------------------------------------------------------------------

- Board authorized distribution of one Right per common share held as of July 7, 2025 record date.
- Each Right entitles holder to purchase 4.57 common shares at $0.01 per share, subject to stockholder approval.
- Rights become exercisable only after stockholder meeting approves Phytanix acquisition and share issuance; exercisable for up to 6 months.
- Rights initially trade with Common Stock, become separable after approval; Rights Agreement with Equiniti Trust Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225016979/0001641172-25-016979-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022899/000164117225016979/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016979

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer